Glaxosmithkline Plc Adr Stock Probability of Future Stock Price Finishing Under 33.7
| GSK Stock | USD 33.70 0.35 1.05% |
GlaxoSmithKline |
GlaxoSmithKline PLC Target Price Odds to finish below 33.7
The tendency of GlaxoSmithKline Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 33.70 | 90 days | 33.70 | under 4 |
Based on a normal probability distribution, the odds of GlaxoSmithKline PLC to move below current price in 90 days from now is under 4 (This GlaxoSmithKline PLC ADR probability density function shows the probability of GlaxoSmithKline Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon GlaxoSmithKline PLC has a beta of 0.28. This usually indicates as returns on the market go up, GlaxoSmithKline PLC average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding GlaxoSmithKline PLC ADR will be expected to be much smaller as well. Additionally GlaxoSmithKline PLC ADR has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. GlaxoSmithKline PLC Price Density |
| Price |
Predictive Modules for GlaxoSmithKline PLC
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as GlaxoSmithKline PLC ADR. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of GlaxoSmithKline PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
GlaxoSmithKline PLC Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. GlaxoSmithKline PLC is not an exception. The market had few large corrections towards the GlaxoSmithKline PLC's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold GlaxoSmithKline PLC ADR, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of GlaxoSmithKline PLC within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.34 | |
β | Beta against Dow Jones | 0.28 | |
σ | Overall volatility | 3.08 | |
Ir | Information ratio | -0.27 |
GlaxoSmithKline PLC Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of GlaxoSmithKline PLC for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for GlaxoSmithKline PLC ADR can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| GlaxoSmithKline PLC generated a negative expected return over the last 90 days | |
| On 10th of October 2024 GlaxoSmithKline PLC paid $ 0.3857 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Global Antacids Market to Cross USD 9 Billion Mark by 2030 DelveInsight |
GlaxoSmithKline PLC Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of GlaxoSmithKline Stock often depends not only on the future outlook of the current and potential GlaxoSmithKline PLC's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. GlaxoSmithKline PLC's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.1 B | |
| Cash And Short Term Investments | 5.7 B |
GlaxoSmithKline PLC Technical Analysis
GlaxoSmithKline PLC's future price can be derived by breaking down and analyzing its technical indicators over time. GlaxoSmithKline Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of GlaxoSmithKline PLC ADR. In general, you should focus on analyzing GlaxoSmithKline Stock price patterns and their correlations with different microeconomic environments and drivers.
GlaxoSmithKline PLC Predictive Forecast Models
GlaxoSmithKline PLC's time-series forecasting models is one of many GlaxoSmithKline PLC's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary GlaxoSmithKline PLC's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about GlaxoSmithKline PLC ADR
Checking the ongoing alerts about GlaxoSmithKline PLC for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for GlaxoSmithKline PLC ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| GlaxoSmithKline PLC generated a negative expected return over the last 90 days | |
| On 10th of October 2024 GlaxoSmithKline PLC paid $ 0.3857 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Global Antacids Market to Cross USD 9 Billion Mark by 2030 DelveInsight |
Check out GlaxoSmithKline PLC Backtesting, GlaxoSmithKline PLC Valuation, GlaxoSmithKline PLC Correlation, GlaxoSmithKline PLC Hype Analysis, GlaxoSmithKline PLC Volatility, GlaxoSmithKline PLC History as well as GlaxoSmithKline PLC Performance. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlaxoSmithKline PLC. If investors know GlaxoSmithKline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlaxoSmithKline PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.28) | Dividend Share 0.61 | Earnings Share 1.54 | Revenue Per Share 15.38 | Quarterly Revenue Growth (0.02) |
The market value of GlaxoSmithKline PLC ADR is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.